Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases

被引:42
作者
Briffod, M
Hacène, K
Le Doussal, V
机构
[1] Ctr Rene Huguenin, Serv Anat & Cytol Pathol, F-92211 St Cloud, France
[2] Ctr Rene Huguenin, Dept Med Stat, F-92211 St Cloud, France
关键词
breast cancer; cell block; fine-needle cytopuncture; immunohistochemistry; lymph node metastasis;
D O I
10.1038/modpathol.3880149
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We assessed the reliability of prognostic biologic markers by means of Immunohistochemistry on cell blocks obtained from diagnostic fine-needle cytopunctures of breast carcinomas and their lymph node metastases. Immunohistochemical studies of MIB-1 (Ki-67), estrogen receptors (ER), progesterone receptors (PR), p53, and c-erb-B-2 were performed in 55 cases of primary breast carcinoma on cell blocks (cytoblock technique) and on their corresponding tissue samples (46 mastectomy specimens and 9 Trucut biopsies) and in 38 cases on cell blocks from fine-needle cytopunctures of both the primary breast tumors and their concurrent lymph node metastases. Interobserver reproducibility ranged from 87 to 100%, depending on the marker. A good correlation was observed between immunostaining assessment on cell. blocks and on the corresponding tumor tissues as follows: Ki-67 (85%), ER (96%), PR (82%), p53 (76%), and c-erb-B-2 (84%). An excellent correlation was observed between cell-block results for primary tumors and node metastases; however, a far higher percentage of Ki-67-positive nuclei was observed in the nodes than in the corresponding tumors in seven cases. All nodes corresponding to ER- or PR-negative tumors were also negative, whereas the nodes corresponding to two ER-positive and one PR-positive tumor were negative. Marked discrepancies were also noted with p53 in two cases and with c-erb-B-2 in two cases. Most discrepancies occurred with Trucut biopsies and with breast tumors that contained a large intraductal component. We conclude that cell. blocks prepared from fine-needle cytopuncture specimens of breast carcinomas and their node metastases are useful when planning neoadjuvant treatment.
引用
收藏
页码:841 / 850
页数:10
相关论文
共 46 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]   EXPRESSION OF RAS P21, P53 AND C-ERBB-2 IN ADVANCED BREAST-CANCER AND RESPONSE TO FIRST LINE HORMONAL-THERAPY [J].
ARCHER, SG ;
ELIOPOULOS, A ;
SPANDIDOS, D ;
BARNES, D ;
ELLIS, IO ;
BLAMEY, RW ;
NICHOLSON, RI ;
ROBERTSON, JFR .
BRITISH JOURNAL OF CANCER, 1995, 72 (05) :1259-1266
[3]  
Balaton AJ, 1996, ANN PATHOL, V16, P144
[4]  
Barbareschi M, 1996, APPL IMMUNOHISTOCHEM, V4, P106
[5]   AN IMMUNOHISTOCHEMICAL EVALUATION OF C-ERB-2 EXPRESSION IN HUMAN-BREAST CARCINOMA [J].
BARNES, DM ;
LAMMIE, GA ;
MILLIS, RR ;
GULLICK, WL ;
ALLEN, DS ;
ALTMAN, DG .
BRITISH JOURNAL OF CANCER, 1988, 58 (04) :448-452
[6]   IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS [J].
BARNES, DM ;
DUBLIN, EA ;
FISHER, CJ ;
LEVISON, DA ;
MILLIS, RR .
HUMAN PATHOLOGY, 1993, 24 (05) :469-476
[7]   Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients [J].
Barnes, DM ;
Harris, WH ;
Smith, P ;
Millis, RR ;
Rubens, RD .
BRITISH JOURNAL OF CANCER, 1996, 74 (09) :1445-1451
[8]  
BATTIFORA H, 1991, MODERN PATHOL, V4, P466
[9]  
BERGER MS, 1988, CANCER RES, V48, P1228
[10]  
BHARGAVA V, 1994, MODERN PATHOL, V7, P361